Abstract |
Primary HIV infection (PHI) and subsequent chronic infection alter B-cell compartment. However, longitudinal analysis defining the dynamics of B-cell alterations are still limited. We longitudinally studied B-cell subsets in individuals followed for 1 year after PHI (n = 40). Treated and untreated chronic HIV infected (n = 56) and HIV-uninfected individuals (n = 58) were recruited as reference groups at the Manhiça District in Mozambique. B cells were analyzed by multicolor flow-cytometry. Anti-HIV humoral response and plasma cytokines were assessed by ELISA or Luminex-based technology. A generalized activation of B cells induced by HIV occurs early after infection and is characterized by increases in Activated and Tissue-like memory cells, decreases in IgM- IgD- (switched) and IgM-only B cells. These alterations remain mostly stable until chronic infection and are reverted in part by ART. In contrast, other parameters followed particular dynamics: PD-1 expression in memory cells decreases progressively during the first year of infection, Transitional B cells expand at month 3-4 after infection, and Marginal zone-like B cells show a late depletion. Plasmablasts expand 2 months after infection linked to plasma viral load and anti-p24 IgG3 responses. Most of well-defined changes induced by HIV in B-cell activation and memory subsets are readily observed after PHI, lasting until ART initiation. However, subsequent changes occur after sustained viral infection. These data indicate that HIV infection impacts B cells in several waves over time, and highlight that early treatment would result in beneficial effects on the B-cell compartment.
|
Authors | Montse Jiménez, Lucía Pastor, Victor Urrea, María Luisa Rodríguez de la Concepción, Erica Parker, Laura Fuente-Soro, Chenjerai Jairoce, Inacio Mandomando, Jorge Carrillo, Denise Naniche, Julià Blanco |
Journal | Frontiers in immunology
(Front Immunol)
Vol. 11
Pg. 614319
( 2020)
ISSN: 1664-3224 [Electronic] Switzerland |
PMID | 33519823
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 Jiménez, Pastor, Urrea, Rodríguez de la Concepción, Parker, Fuente-Soro, Jairoce, Mandomando, Carrillo, Naniche and Blanco. |
Chemical References |
- Anti-Retroviral Agents
- Cytokines
- Immunoglobulin D
- Immunoglobulin G
- Immunoglobulin M
- PDCD1 protein, human
- Programmed Cell Death 1 Receptor
|
Topics |
- Adult
- Anti-Retroviral Agents
(therapeutic use)
- B-Lymphocyte Subsets
(immunology)
- B-Lymphocytes
(immunology)
- Chronic Disease
- Cohort Studies
- Cytokines
(blood)
- Flow Cytometry
- HIV Infections
(drug therapy, immunology, pathology, virology)
- HIV-1
(immunology)
- Humans
- Immunity, Humoral
- Immunoglobulin D
(immunology)
- Immunoglobulin G
(immunology)
- Immunoglobulin M
(immunology)
- Longitudinal Studies
- Lymphocyte Activation
- Mozambique
(epidemiology)
- Programmed Cell Death 1 Receptor
(metabolism)
- Prospective Studies
- Viral Load
|